Loading clinical trials...
Loading clinical trials...
Detection of Early Lung Cancer Among Military Personnel Study 2 (DECAMP-2): Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer
Conditions
Interventions
Biosamples from airway and blood
Locations
15
United States
Regents of the University of California LA (Los Angeles VA Healthcare System)
Los Angeles, California, United States
University of California Los Angeles Medical Center
Los Angeles, California, United States
Naval Medical Center San Diego
San Diego, California, United States
Denver Research Institute
Denver, Colorado, United States
Walter Reed National Military Medical Center
Bethesda, Maryland, United States
Boston University Medical Center
Boston, Massachusetts, United States
Start Date
September 1, 2011
Primary Completion Date
December 1, 2027
Completion Date
December 1, 2027
Last Updated
April 1, 2026
NCT05746039
NCT06712563
NCT07477600
NCT05878769
NCT06717659
NCT07274631
Lead Sponsor
Boston University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions